EUVIMEDEUVIMED entdecken
Crossref

Long-term clinical outcomes and complications of Descemet membrane endothelial keratoplasty: A retrospective analysis of 1000 consecutive eyes

Samar K Basak, Soham Basak

Journal of Cornea and Ocular Surface · 2023

DOI: 10.4103/jcos.jcos_10_22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cornea and Ocular Surface, 2023. Verfasst von Samar K Basak und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Descemet Membrane Endothelial Keratoplasty (DMEK) is an established form of endothelial keratoplasty using only donor DM with healthy endothelium to treat corneal endothelial diseases.

Objectives

To analyze the overall long-term outcomes and complications of DMEK in 1000 consecutive cases. Materials and Methods: A retrospective review of the electronic medical records (EMR) of consecutive interventional series of DMEKs operated by a single surgeon, between July 2016 and December 2021 in a tertiary referral center, were included in this study. All the grafts were prepared by the operating surgeon during the procedure, using McCarey Kaufman medium- or Cornisol-preserved cornea with an endothelial cell density (ECD) of ≥2500 cells/mm 2 . Indications, preoperative and postoperative best spectacle-corrected visual acuity (BSCVA), ECD, endothelial cell loss (ECL), and complications were analyzed between 3 months and 5 years.

Results

Nine hundred sixty-nine eyes from the EMR met the inclusion criteria for analysis. The most common indication was post-cataract corneal edema/bullous keratopathy in 428 (44.1%) eyes followed by Fuchs’ endothelial corneal dystrophy in 354 (36.5%) eyes. Other visual comorbidities were present in 183 (18.9%) eyes. In 384 (39.6%) eyes, DMEK was combined with cataract surgery (triple-DMEK) in phakic eyes with cataract. BSCVA of ≥20/25 was achieved in 41.8%, 48.1%, 47.5%, and 44.6% of eyes at 3, 6, 12, and 60 months, respectively, and remained stable ( P = 0.54). The mean ECL was 22.8% ± 17%, 32.5% ± 16%, 34.8% ± 17%, 38.1% ± 17%, 41.3% ± 18%, 45.0% ± 19, and 48.4% ± 18% after 3, 6, 12, 24, 36, 48, and 60 months, respectively ( P < 0.05 for all time points). The most common complication was DM detachment in 119 (12.3%) eyes, of which 69 (7.1%) eyes required rebubbling. Three (0.3%) eyes had primary graft failure and 59 (6.1%) eyes had secondary graft failure. Endothelial rejection occurred in 37 (3.8%) eyes till the last follow-up visit.

Conclusion

The long-term visual outcomes of DMEK were highly encouraging in this large series. Overall complications were less, and the ECL up to 5 years was acceptable.

Zitieren

APA

Basak, S. K., & Basak, S. (2023). Long-term clinical outcomes and complications of Descemet membrane endothelial keratoplasty: A retrospective analysis of 1000 consecutive eyes. Journal of Cornea and Ocular Surface. https://doi.org/10.4103/jcos.jcos_10_22

Vancouver

Basak SK, Basak S. Long-term clinical outcomes and complications of Descemet membrane endothelial keratoplasty: A retrospective analysis of 1000 consecutive eyes. Journal of Cornea and Ocular Surface. 2023. doi:10.4103/jcos.jcos_10_22

BibTeX
@article{Basak2023,
  author = {Basak, Samar K and Basak, Soham},
  title = {Long-term clinical outcomes and complications of Descemet membrane endothelial keratoplasty: A retrospective analysis of 1000 consecutive eyes},
  journal = {Journal of Cornea and Ocular Surface},
  year = {2023},
  doi = {10.4103/jcos.jcos_10_22}
}
Kostenlos starten →